StratifiCare

About:

StratifiCare is a medical device that utilizes severe dengue diagnostics.

Website: http://www.stratificare.com

Top Investors: ADB Ventures, Enterprise Singapore, Quek Siu Rui, Ministry of Health Singapore, Jeffrey Tiong

Description:

StratifiCare is a medical company that focuses on the development and manufacturing of in vitro diagnostic medical devices it provides solutions for personalized medicine. StratifiCare features a panel of biomarkers which are able to determine the progress of dengue fever. The company was founded on July 13, 2015, and headquartered in Singapore.

Total Funding Amount:

$2.73M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Singapore, Central Region, Singapore

Founded Date:

2015-07-13

Contact Email:

general(AT)stratificare.com

Founders:

Anthony Chua, Keith Mun Keat Chong, Mary Mah Lee Ng, Tiffany Fan Lin

Number of Employees:

1-10

Last Funding Date:

2021-09-07

IPO Status:

Private

Industries: